"Histological and Immunohistochemical Study of the Protective Effect of Sodium Glucose Co-transporter 2 (SGLT2) Inhibitors on Streptozotocin Induced Pancreatic Damage In Adult Male Albino Rats" | ||
| Minia Journal of Medical Research | ||
| Articles in Press, Accepted Manuscript, Available Online from 17 March 2025 | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mjmr.2025.358993.1898 | ||
| Authors | ||
| youssra Magdy Hassan* 1; Abdel Hamid Sayed AboBakr2; Medhat Ata3; Mohamed Ahmed Desouky4 | ||
| 1Anatomy and Embryology department Faculty of medicine Minia university | ||
| 2Assistant professor of Anatomy and Embryology, Faculty of Medicine, Minia University, Egypt | ||
| 3Assistant professor of Anatomy and Embryology Faculty of Medicine, Minia University | ||
| 4Anatomy and Embryology department Faculty of medicine Minia university | ||
| Abstract | ||
| Background: SGLT2 inhibitor is a type of medication prescribed for treatment of type 2 diabetes. By prevention the reabsorption of glucose in the kidneys, these drugs facilitate glucose removal through urine. Aim: Investigate protective effect SGLT2 inhibitors on pancreatic damage induced by streptozotocin. Materials and Methods: Study involved forty adult male albino rats; they were divided into four groups. Group I: consisted of 10 rats administered three ml distilled water orally once daily. Group II: This group included 10 rats administered Jardiance (Empagliflozin, an SGLT2 inhibitor) at a dose of 10 mg/kg/day, dissolved in drinking water for 28 days. Group III: This group included 10 rats fasted for 12 hours before receiving a single dose of streptozotocin (50 mg/kg) intraperitoneally to induce pancreatic damage. Group IV: This group included 10 rats that received Jardiance (Empagliflozin, an SGLT2 inhibitor) at a dose of 10 mg/kg/day, dissolved in drinking water for 14 days before STZ injection. Then, rats were injected with a single dose of streptozotocin (50 mg/kg) intraperitoneally and continued to receive the daily dose of Jardiance for 14 days. At end of the experiment (28 days), pancreatic tissue samples were collected for H&E staining and immunohistochemical analysis. Results: Degenerative changes were observed in the pancreas of Group III. Protection with SGLT2 inhibitors attenuated degenerative effects, demonstrating a protective effect on pancreatic tissue. Conclusion: SGLT2 inhibitors effectively attenuate the degenerative effects induced by streptozotocin in the pancreas. These results suggest that SGLT2 inhibitors offer a therapeutic strategy for protecting pancreatic tissue. | ||
| Keywords | ||
| Sodium glucose co-transporter 2 inhibitors; streptozotocin; Pancreas | ||
|
Statistics Article View: 90 |
||
